AProf David Pryor

A/Prof David Pryor

BSc, MBBS, FRANZCR
Radiation Oncologist
Become a Patient

Biography

A/Prof David Pryor is an experienced radiation oncologist Icon Cancer Centre Greenslopes and Icon Cancer Centre Redland. He specialises in the management of urological cancer, gastrointestinal cancer, thoracic cancer, soft tissue sarcoma and skin cancers and the use of highly focused stereotactic radiation therapy and palliative radiotherapy.

He is committed to providing high quality cancer care and believes in driving education, quality improvement, research and innovation through his leadership roles in Icon Cancer Centre’s stereotactic radiation therapy network, Adjunct Associate Professor at the Queensland University of Technology, senior lecturer with the University of Queensland, chair of the QLD steering committee for the Prostate Cancer Outcomes Registry (PCOR-ANZ) and immediate past chair of the Genitourinary Committee of the Trans-Tasman Radiation Oncology Group (TROG). He is the national co-chair of studies evaluating the role of stereotactic radiotherapy in the management of oligometastatic cancers and in early-stage liver cancer and a member of the trial management committee for numerous other collaborative group trials in prostate, bladder, kidney, gastrointestinal and soft tissue tumours.

Affiliations & Memberships

  • Royal Australian and New Zealand College of Radiologists (RANZCR)
  • Trans Tasman Radiation Oncology Group (TROG)
  • Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP)
  • Australasian GastroIntestinal Trials Group (AGITG)
  • Australian Sarcoma Study Group (ASSG)
  • International Stereotactic Radiosurgery Society (ISRS)

Special Interests

A/Prof David Pryor accepts referrals for all cancer types, with special clinical interest in:
  • Gastrointestinal cancer
  • Prostate cancer
  • Sarcoma
  • Stereotactic radiation therapy

Icon Locations

Greenslopes View centre
Redland View centre

Visiting Locations

  • Princess Alexandra Hospital

Publications

  • Stereotactic body radiotherapy in the management of hepatocellular carcinoma: An Australian multi-institutional patterns of practice review. H. Liu, Y. Lee, S. Sridharan, E. Choong, H. Le, W. Wang, R. Khor, J. Chu, A. Oar, R. Mott, J. Smart, T. Jenkins, N. Anderson, S. Cross, K. Loo, A. Wigg, K. Stuart, & D. Pryor. Journal of medical imaging and radiation oncology, 2021; 65(3), 365–373.